Free Cash Flow

Climbing Entrepreneur's Franchise 500, this Verizon retailer reveals a model built on rapid growth, robust franchisee support, and deep community roots.

Pharma giant AbbVie raises its dividend, backed by robust financials and a powerful drug pipeline that signals a thriving post-Humira growth era.

A new platform from a firm managing $1.3T is giving high-net-worth individuals the same powerful wealth tools once reserved only for billionaires.

Cloud security leader Zscaler prepares for high-stakes investor conferences, aiming to showcase its financial strength and AI-driven growth strategy.

Princeton NuEnergy hires a battery industry titan to spearhead its commercial push, aiming to dominate the booming U.S. battery recycling market.

Reunion Neuroscience hits the investor conference circuit, seeking capital to advance its groundbreaking psychedelic-inspired therapies for depression and anxiety.

Benefits giant Alight faces a massive $3.1B annual loss from a goodwill writedown, suspending its dividend to focus on debt reduction and AI innovation.

BrainsWay's strategic investment in BrainStim aims to expand Deep TMS access in Canada, targeting veterans and first responders with advanced mental health care.

With two blockbuster cancer drugs driving record revenue, all eyes are on Syndax's upcoming earnings call for its 2026 outlook and growth strategy.

The safety science giant posted record 2025 earnings and a strong 2026 outlook, sharpening its focus on high-growth tech with a key divestiture.

Riding a wave of strong financial performance, the aerospace materials giant is boosting its buyback authorization to $620 million, underscoring its bullish outlook.

As Signet prepares its Q4 earnings, all eyes are on whether its brand power can overcome cautious consumer spending and set the tone for the luxury market.

Specialist asset manager Sprott Inc. leverages a volatile market and geopolitical tensions, riding a precious metals boom to record profits and AUM growth.

Amid regional conflict, InterCure reports NIS 265M revenue, enters German market, and makes strategic US moves, showcasing remarkable resilience and growth.

Cenovus Energy reports a record-breaking quarter, with upstream production soaring past 900,000 BOE/d after its landmark acquisition of MEG Energy.

Early data reveals a novel immunotherapy, STC-1010, may activate the immune system against a common, treatment-resistant form of colorectal cancer.

Despite a massive accounting-driven net loss, Renault Group's 2025 results reveal robust operational health, sales growth, and a successful EV push.

As VerticalScope preps its 2025 results, investors watch if its pivot to AI and e-commerce can overcome ad market and search engine challenges.

The Canadian miner announces its first-ever dividend and a share buyback, balancing ambitious growth with a new focus on returning capital to investors.

Riding a wave of record free cash flow and a bullish gold market, Kinross has announced a significant dividend increase, signaling confidence to investors.